VALIDATE Network
@NetworkValidate
Followers
1K
Following
2K
Media
678
Statuses
7K
International network of researchers aiming to accelerate vaccine development for TB, leishmaniasis, melioidosis &leprosy. Led by @UniofOxford - open to all
Oxford, England
Joined July 2017
We are happy to announce that VALIDATE now boasts over 900 members! In total, we have 905 members across 375 institutes and organisations in 78 countries, including 48 Lower and Middle-Income Countries. Join VALIDATE today:
0
3
2
Paper: Unleashing the power of the BCG vaccine in modulating viral immunity through heterologous protection: A scoping review
0
0
2
Immunization experts urge stronger action to close vaccination gaps in Africa.
0
0
0
Paper: Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials - The Lancet Respiratory Medicine
0
0
0
Paper: The delivery of new tuberculosis vaccines to people living with HIV – when to vaccinate?.
0
3
0
Bacille Calmette-Guérin Revaccination Fails to Prevent Sustained Tuberculosis Infection.
0
0
0
Paper: Mycobacterium tuberculosis biology, pathogenicity and interaction with the host.
0
1
3
We are really excited to be hosting our 2025 'VALIDATE for Schools' event today, with ~80 school kids learning about #leishmaniasis, vaccines, and how to create a science poster - good luck (& thank you!) to the VALIDATE members who are helping run the event #superstars🍀.
0
0
0
Paper: The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research? - The Lancet Infectious Diseases
0
0
0
Paper: MetE: A Promising Protective Antigen for Tuberculosis Vaccine Development (Provisionally accepted).
0
1
1
Lancet warns of rising disease outbreaks as global childhood vaccination rates decline.
0
0
1
Corrigendum to “Recombinant BCGΔBCG1419c protects outbred mice against. (Authors include VALIDATE member Mario A. Flores-Valdez).
0
0
1
Paper: Optimal control and sensitivity analysis of a mathematical model for MDR-TB transmission with advanced treatment strategies.
0
0
1
Provisionally accepted paper: Protection and diagnostic interference induced by heat inactivated, phage-inactivated and live vaccine prototypes against animal tuberculosis.
0
0
2
Provisionally accepted paper: CD1-restricted T cells: Are unconventional allies the key to future TB vaccines?.
0
0
0
RT @NatureCareers: Losing my supervisors during my PhD was a challenge I never anticipated. Their mentorship was invaluable, and their abse….
0
1
0
Paper: Evaluation of the Immunogenicity of a Mycobacterium intracellulare Clinical IsolateEvaluation of the Immunogenicity of a Mycobacterium intracellulare Clinical Isolate
0
0
0
RT @impact_tb: WHO Publishes updated guidelines for quantifying the often devastating costs of TB for families:.
0
2
0